Maternal Age at Menarche Genes Determines Fetal Growth Restriction Risk

被引:1
|
作者
Reshetnikov, Evgeny [1 ]
Churnosova, Maria [1 ]
Reshetnikova, Yuliya [1 ]
Stepanov, Vadim [2 ]
Bocharova, Anna [2 ]
Serebrova, Victoria [2 ]
Trifonova, Ekaterina [2 ]
Ponomarenko, Irina [1 ]
Sorokina, Inna [1 ]
Efremova, Olga [1 ]
Orlova, Valentina [1 ]
Batlutskaya, Irina [1 ]
Ponomarenko, Marina [1 ]
Churnosov, Vladimir [1 ]
Aristova, Inna [1 ]
Polonikov, Alexey [1 ,3 ,4 ]
Churnosov, Mikhail [1 ]
机构
[1] Belgorod State Natl Res Univ, Dept Med Biol Disciplines, Belgorod 308015, Russia
[2] Russian Acad Sci, Res Inst Med Genet, Tomsk Natl Res Med Ctr, Tomsk 634050, Russia
[3] Kursk State Med Univ, Dept Biol Med Genet & Ecol, Kursk 305041, Russia
[4] Kursk State Med Univ, Res Inst Genet & Mol Epidemiol, Kursk 305041, Russia
关键词
fetal growth restriction; single nucleotide polymorphism; association; age at menarche; GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; FTO RS9939609 POLYMORPHISM; ESTROGEN-RECEPTOR-ALPHA; VITAMIN-D-RECEPTOR; BSMI POLYMORPHISM; KISSPEPTIN LEVELS; CANDIDATE GENES; BLOOD-PRESSURE; FAT-MASS;
D O I
10.3390/ijms25052647
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We aimed to explore the potential link of maternal age at menarche (mAAM) gene polymorphisms with risk of the fetal growth restriction (FGR). This case (FGR)-control (FGR free) study included 904 women (273 FGR and 631 control) in the third trimester of gestation examined/treated in the Departments of Obstetrics. For single nucleotide polymorphism (SNP) multiplex genotyping, 50 candidate loci of mAAM were chosen. The relationship of mAAM SNPs and FGR was appreciated by regression procedures (logistic/model-based multifactor dimensionality reduction [MB-MDR]) with subsequent in silico assessment of the assumed functionality pithy of FGR-related loci. Three mAAM-appertain loci were FGR-linked to genes such as KISS1 (rs7538038) (effect allele G-odds ratio (OR)allelic = 0.63/pperm = 0.0003; ORadditive = 0.61/pperm = 0.001; ORdominant = 0.56/pperm = 0.001), NKX2-1 (rs999460) (effect allele A-ORallelic = 1.37/pperm = 0.003; ORadditive = 1.45/pperm = 0.002; ORrecessive = 2.41/pperm = 0.0002), GPRC5B (rs12444979) (effect allele T-ORallelic = 1.67/pperm = 0.0003; ORdominant = 1.59/pperm = 0.011; ORadditive = 1.56/pperm = 0.009). The haplotype ACA FSHB gene (rs555621*rs11031010*rs1782507) was FRG-correlated (OR = 0.71/pperm = 0.05). Ten FGR-implicated interworking models were founded for 13 SNPs (pperm <= 0.001). The rs999460 NKX2-1 and rs12444979 GPRC5B interplays significantly influenced the FGR risk (these SNPs were present in 50% of models). FGR-related mAAM-appertain 15 polymorphic variants and 350 linked SNPs were functionally momentous in relation to 39 genes participating in the regulation of hormone levels, the ovulation cycle process, male gonad development and vitamin D metabolism. Thus, this study showed, for the first time, that the mAAM-appertain genes determine FGR risk.
引用
收藏
页数:26
相关论文
共 50 条
  • [31] SMOKING, MATERNAL AGE, AND FETAL GROWTH
    CNATTINGIUS, S
    AXELSSON, O
    EKLUND, G
    LINDMARK, G
    OBSTETRICS AND GYNECOLOGY, 1985, 66 (04): : 449 - 452
  • [32] Association of maternal xenobiotic-metabolizing gene polymorphisms with risk of fetal growth restriction
    Yu, Ling
    Hu, Yun
    Ding, Yiling
    PERSONALIZED MEDICINE, 2019, 16 (04) : 269 - 276
  • [33] Longitudinal maternal haemodynamics in fetal growth restriction in pregnancies at high risk for placental insufficiency
    Stott, D.
    Papastefanou, I
    Clark, K.
    Paraschiv, D.
    Kametas, N.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 : 133 - 133
  • [34] Fetal cells in maternal blood of pregnancies with severe fetal growth restriction
    Al-Mufti, R
    Lees, C
    Albaiges, G
    Hambley, H
    Nicolaides, KH
    HUMAN REPRODUCTION, 2000, 15 (01) : 218 - 221
  • [35] Maternal interventricular vein of the heart and fetal growth restriction
    Kuusela, Pekka J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (03) : 285 - 286
  • [36] Fetal growth restriction: composite maternal and neonatal morbidity
    Mendez-Figueroa, Hector
    Maggio, Lindsay
    Dahlke, Joshua
    Albright, Catherine
    Ayala, Nina
    Chauhan, Suneet
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (01) : S75 - S75
  • [37] MATERNAL EXPOSURE TO PERFLUORINATED ACIDS AND FETAL GROWTH RESTRICTION
    Hamm, M. P.
    Martin, J. W.
    Chan, E.
    Cherry, N. M.
    Burstyn, I.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 : S43 - S43
  • [38] The Association between Fetal Growth Restriction and Maternal Morbidity
    Hage Diab, Yara
    Martins, Juliana G.
    Saade, George
    Kawakita, Tetsuya
    AMERICAN JOURNAL OF PERINATOLOGY, 2024, 41 : e2195 - e2201
  • [39] Maternal Melatonin as an Antioxidant in Fetal Growth Restriction.
    Alers, Nicole O.
    Yen Pham
    Jenkin, Graham
    Miller, Suzanne L.
    Wallace, Euan M.
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 168A - 169A
  • [40] Maternal serum copeptin as a marker for fetal growth restriction
    Foda, Ashraf
    Aal, Ibrahim
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2013, 18 (03) : 159 - 164